Home
Browse
Search
Statistics
About
Usage
PMID: 21538969
Ren CL, Desai H, Platt M, Dixon M
Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Pediatr Pulmonol. 2011 Apr 29. doi: 10.1002/ppul.21475., 2011-04-29
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
10
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:10:29
status:
NEW
view ABCC7 p.Arg117His details
One patient with the F508del/
R117H
/7T genotype was reassigned the diagnosis of CF after he had a positive OP culture for Pa, and his follow up sweat Cl at 1 year of life was 73 mmol/L.
Login to comment
57
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:57:211
status:
NEW
view ABCC7 p.Arg117His details
However, since the New York state panel includes all the CF causing mutations (Group A),1,5 a mutation identified on sequencing would not have affected the diagnosis of CRMS. Three CRMS patients had the F508del/
R117H
/ 7T genotype, which has been associated with a variable CF phenotype.6-8 Compared to CF infants, CRMS infants` mean fecal elastase values were normal, and none of the CRMS infants had pancreatic insufficiency.
Login to comment
58
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:58:211
status:
NEW
view ABCC7 p.Arg117His details
However, since the New York state panel includes all the CF causing mutations (Group A),1,5 a mutation identified on sequencing would not have affected the diagnosis of CRMS. Three CRMS patients had the F508del/
R117H
/ 7T genotype, which has been associated with a variable CF phenotype.6-8 Compared to CF infants, CRMS infants` mean fecal elastase values were normal, and none of the CRMS infants had pancreatic insufficiency.
Login to comment
60
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21538969:60:256
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:60:296
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:60:567
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 21538969:60:312
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21538969:60:262
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21538969:60:276
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21538969:60:336
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21538969:60:342
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 21538969:60:510
status:
NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21538969:60:269
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21538969:60:250
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 21538969:60:324
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 21538969:60:437
status:
NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 21538969:60:467
status:
NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 21538969:60:473
status:
NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 21538969:60:331
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 21538969:60:479
status:
NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21538969:60:318
status:
NEW
view ABCC7 p.Arg560Thr details
Infants in both groups received treatment with inhaled tobramycin if they had a positive Pa OP culture, and treatment in both groups was associated with eradication of TABLE 1-CFTR Gene Mutation Panel Used by New York CF NBS Program F508del I50e7del
G542X
G551D
W1282X
N1303K
R553X
621þ1G>T
R117H
1717-1G>A
A455E
R560T
R1162X
G85E
R334W
R347P
711þ1G>T 1898þ1G>A 2184delA 1078delT 3849þ10kbC>T 2789þ5G>A 3659delC
I148T
3120þ1G>A 3876delA
V520F
S549R
S549N
3849þ4 A-G 3905insT
R347H
Reflex testing for 5T polymorphism is performed if
R117H
is detected.
Login to comment
61
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21538969:61:257
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:61:297
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:61:568
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 21538969:61:313
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21538969:61:263
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21538969:61:277
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21538969:61:337
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21538969:61:343
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 21538969:61:511
status:
NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21538969:61:270
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21538969:61:251
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 21538969:61:325
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 21538969:61:438
status:
NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 21538969:61:468
status:
NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 21538969:61:474
status:
NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 21538969:61:332
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 21538969:61:480
status:
NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21538969:61:319
status:
NEW
view ABCC7 p.Arg560Thr details
Infants in both groups received treatment with inhaled tobramycin if they had a positive Pa OP culture, and treatment in both groups was associated with eradication of TABLE 1- CFTR Gene Mutation Panel Used by New York CF NBS Program F508del I50e7del
G542X
G551D
W1282X
N1303K
R553X
621þ1G>T
R117H
1717-1G>A
A455E
R560T
R1162X
G85E
R334W
R347P
711þ1G>T 1898þ1G>A 2184delA 1078delT 3849þ10kbC>T 2789þ5G>A 3659delC
I148T
3120þ1G>A 3876delA
V520F
S549R
S549N
3849þ4 A-G 3905insT
R347H
Reflex testing for 5T polymorphism is performed if
R117H
is detected.
Login to comment
74
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:74:32
status:
NEW
view ABCC7 p.Arg117His details
This infant carried the F508del/
R117H
/ 7T genotype and had a Pa positive OP culture; his diagnosis was subsequently changed to CF.
Login to comment
75
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:75:32
status:
NEW
view ABCC7 p.Arg117His details
This infant carried the F508del/
R117H
/ 7T genotype and had a Pa positive OP culture; his diagnosis was subsequently changed to CF.
Login to comment
77
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:77:44
status:
NEW
view ABCC7 p.Arg117His details
However, one infant who carried the F508del/
R117H
/7T genotype subsequently had a Pa positive OP culture and elevated follow up sweat Cl level, leading to a change in diagnosis to CF.
Login to comment
78
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:78:44
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:78:330
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:78:391
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:78:454
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:78:967
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21538969:78:961
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21538969:78:849
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21538969:78:906
status:
NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Tyr1032Cys
X
ABCC7 p.Tyr1032Cys 21538969:78:798
status:
NEW
view ABCC7 p.Tyr1032Cys details
TABLE 3- Clinical Features and Outcomes of t
he CR
MS Infants Patient number Gender Race/ ethnicity Mean age at 1st sweat (weeks) Mean sweat chloride (range) CFTR gene mutations identified Follow up time (months) Fecal elastase (mcg/gm stool) History of Pa infection History of hospitalization 1 Male Caucasian 4 46 (38-54) F508del/
R117H
/7T 36 303 Yes No 2 Male Caucasian 5 40 (40-43) F508del/
R117H
/7T 60 500 Yes No 3 Female Caucasian 3 29 (27-31) F508del/
R117H
/7T 60 488 No No 4 Male Caucasian 3 34 (33-38) F508del/none 26 383 No No 5 Male Caucasian 3 45 (40-50) F508del/none 72 424 No No 6 Female Caucasian 3 35 (32-38) F508del/none 9 454 No No 7 Male Caucasian 3 41 (36-46) F508del/none 39 462 No No 8 Female Caucasian 5 50 (46-52) F508del/none 72 440 No Yes 9 Male Caucasian 4 43 (41-45) F508del/
Y1032C
14 401 No No 10 Male Caucasian 3 52 (50-54)
G542X
/none 21 500 No No 11 Female Caucasian 8 34 (30-38)
R560T
/none 9 433 No No 12 Female Hispanic 6 36 (32-40)
R334W
/
R117H
/7T 24 500 Yes No Mean sweat chloride levels represent the mean of all tests performed in the neonatal period.
Login to comment
79
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:79:330
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:79:391
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:79:454
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:79:967
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21538969:79:961
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21538969:79:849
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21538969:79:906
status:
NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Tyr1032Cys
X
ABCC7 p.Tyr1032Cys 21538969:79:798
status:
NEW
view ABCC7 p.Tyr1032Cys details
TABLE 3- Clinical Features and Outcomes of the CRMS Infants Patient number Gender Race/ ethnicity Mean age at 1st sweat (weeks) Mean sweat chloride (range) CFTR gene mutations identified Follow up time (months) Fecal elastase (mcg/gm stool) History of Pa infection History of hospitalization 1 Male Caucasian 4 46 (38-54) F508del/
R117H
/7T 36 303 Yes No 2 Male Caucasian 5 40 (40-43) F508del/
R117H
/7T 60 500 Yes No 3 Female Caucasian 3 29 (27-31) F508del/
R117H
/7T 60 488 No No 4 Male Caucasian 3 34 (33-38) F508del/none 26 383 No No 5 Male Caucasian 3 45 (40-50) F508del/none 72 424 No No 6 Female Caucasian 3 35 (32-38) F508del/none 9 454 No No 7 Male Caucasian 3 41 (36-46) F508del/none 39 462 No No 8 Female Caucasian 5 50 (46-52) F508del/none 72 440 No Yes 9 Male Caucasian 4 43 (41-45) F508del/
Y1032C
14 401 No No 10 Male Caucasian 3 52 (50-54)
G542X
/none 21 500 No No 11 Female Caucasian 8 34 (30-38)
R560T
/none 9 433 No No 12 Female Hispanic 6 36 (32-40)
R334W
/
R117H
/7T 24 500 Yes No Mean sweat chloride levels represent the mean of all tests performed in the neonatal period.
Login to comment
101
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:101:25
status:
NEW
view ABCC7 p.Arg117His details
Infants with the F508del/
R117H
/7T genotype represent a subgroup of CRMS, and the relationship between TABLE 5- Nutritional Outcomes in CF and CRMS Patients Age (years) Weight for Age Z score Height for age Z score 1 2 3 4 3 4 CF N 27 24 20 16 20 16 Mean (SD) À0.49 (1.02) À0.16 (0.97) 0.02 (1.06) 0.05 (1.116) À0.01 (0.94) À0.04 (0.94) CRMS N 12 9 6 4 6 4 Mean (SD) 0.41 (0.99) 0.88 (0.91) 1.07 (1.14) 0.76 (.74) 0.56 (0.53) 0.63 (0.63) Data represent the mean of all measurements obtained in a given year.
Login to comment
102
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21538969:102:25
status:
NEW
view ABCC7 p.Arg117His details
Infants with the F508del/
R117H
/7T genotype represent a subgroup of CRMS, and the relationship between TABLE 5- Nutritional Outcomes in CF and CRMS Patients Age (years) Weight for Age Z score Height for age Z score 1 2 3 4 3 4 CF N 27 24 20 16 20 16 Mean (SD) À0.49 (1.02) À0.16 (0.97) 0.02 (1.06) 0.05 (1.116) À0.01 (0.94) À0.04 (0.94) CRMS N 12 9 6 4 6 4 Mean (SD) 0.41 (0.99) 0.88 (0.91) 1.07 (1.14) 0.76 (.74) 0.56 (0.53) 0.63 (0.63) Data represent the mean of all measurements obtained in a given year.
Login to comment